Incidence of cardiovascular events in patients treated with immune checkpoint inhibitors

Back

ESC Professional Premium Access

Incidence of cardiovascular events in patients treated with immune checkpoint inhibitors

Session: Cardio-oncology revisited

Topic: Cardio-Oncology

Speaker: Doctor D. Laenens (Leiden, NL)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Dorien Laenens

Leiden University Medical Center, Leiden (Netherlands (The))

1 presentation

0 follower

4 more presentations in this session

Cardiotoxicity in Ewing- and osteosarcoma: a 40 year experience from a tertiary sarcoma center

Speaker: Mr J. Heemelaar (Leiden, NL)

HFA-ICOS cardiovascular toxicity risk score validation in CARDIOTOX registry

Speaker: Doctor B. Rivero Santana (Madrid, ES) Doctor A. Severo (Madrid, ES)

High risk of cardiovascular disease in curatively treated patients with oesophageal cancer: a danish cohort study

Speaker: Doctor M. Soendergaard (Aarhus N, DK)

Mortality and major adverse cardiac events in women with breast cancer receiving radiotherapy: a 10-year cohort study of patients and population controls

Speaker: Doctor J. Jacobs (Leuven, BE)

Access the full session

Cardio-oncology revisited

Speakers: Doctor D. Laenens, Mr J. Heemelaar, Doctor B. Rivero Santana, Doctor A. Severo, Doctor M. Soendergaard...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources